IPCA Laboratories Limited — Board Meeting, 13-01-2026: Outcome of Board Meeting
13-01-2026 | 10:42 am
13-01-2026 | 10:42 am
Ipca Lab's US subsidiary will sell its entire stake in Bayshore Pharma LLC for $400,000 to Centaur Pharma USA Inc. Bayshore, now dormant, is being sold to cut compliance costs.
No comments yet. Be the first to comment!
